Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Muscarinic acetylcholine receptor M3 (M3 mAChR) is a G protein-coupled receptor that mediates smooth muscle contraction throughout the body, stimulates glandular secretion, and regulates insulin secretion. It is an important target for drugs affecting smooth muscle tone or glandular secretions, particularly in the treatment of asthma and COPD.
Agonists stimulate M3 mAChR, leading to Gq/11 activation, increased phospholipase C activity, increased IP3 and DAG production, and elevated intracellular calcium levels, resulting in smooth muscle contraction and glandular secretion. Antagonists block M3 mAChR, preventing acetylcholine binding and subsequent downstream signaling, leading to smooth muscle relaxation and reduced glandular secretion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptor M3 (M3 mAChR).